Nardilysin in vascular smooth muscle cells controls blood pressure via the regulation of calcium dynamics

Biochem Biophys Res Commun. 2024 Jun 18:712-713:149961. doi: 10.1016/j.bbrc.2024.149961. Epub 2024 Apr 16.


Blood pressure is a crucial physiological parameter and its abnormalities can cause a variety of health problems. We have previously reported that mice with systemic deletion of nardilysin (NRDC), an M16 family metalloprotease, exhibit hypotension. In this study, we aimed to clarify the role of NRDC in vascular smooth muscle cell (VSMC) by generating VSMC-specific Nrdc knockout (VSMC-KO) mice. Our findings reveal that VSMC-KO mice also exhibit hypotension. Aortas isolated from VSMC-KO mice exhibited a weakened contractile response to phenylephrine, accompanied by reduced phosphorylation of myosin light chain 2 and decreased rhoA expression. VSMC isolated from VSMC-KO aortas showed a reduced increase in intracellular Ca2+ concentration induced by α-stimulants. These findings suggest that NRDC in VSMC regulates vascular contraction and blood pressure by modulating Ca2+ dynamics.

Keywords: Blood pressure; Calcium dynamics; Myosin light chain; Nardilysin; Vascular smooth muscle cell; rhoA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / cytology
  • Aorta / metabolism
  • Blood Pressure*
  • Calcium Signaling
  • Calcium* / metabolism
  • Cells, Cultured
  • Hypotension / metabolism
  • Male
  • Metalloendopeptidases* / genetics
  • Metalloendopeptidases* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout*
  • Muscle, Smooth, Vascular* / cytology
  • Muscle, Smooth, Vascular* / drug effects
  • Muscle, Smooth, Vascular* / metabolism
  • Myocytes, Smooth Muscle* / drug effects
  • Myocytes, Smooth Muscle* / metabolism
  • Vasoconstriction / drug effects


  • Calcium
  • nardilysin
  • Metalloendopeptidases